Kathryn Clarke

700 citations
5 papers · 568 indexed · h-index 4
Topics
Cancer Treatment and Pharmacology (4 papers)Breast Cancer Treatment Studies (2 papers)Chemotherapy-related skin toxicity (2 papers)
Partner nations
United StatesIreland

In The Last Decade

Kathryn Clarke

5 papers receiving 550 citations

Peers

Kathryn Clarke
Comparison fields: 5 of 58
  • Oncology 488
  • Cancer Research 147
  • Radiology, Nuclear Medicine and Imaging 120
  • Molecular Biology 88
  • Pulmonary and Respiratory Medicine 86
Replace J.L. Ostrowski with:
J.L. Ostrowski United Kingdom
H.A. Burris United States
Guillermo Lerzo Argentina
F. De Vita Italy
D. Ilegbodu United States
Patricia Tresca France
Angela Sciandivasci Italy
A. Chlistalla United Kingdom
Patricia Gómez Spain
K. L. Blackwell United States
Kathryn Clarke relative to J.L. Ostrowski United Kingdom J.L. Ostrowski's profile →
Citations per field
00.5×1.5×2.3×
J.L. Ostrowski · 1×
Citations per year

Countries citing papers authored by Kathryn Clarke

Since Specialization
Citations

This map shows the geographic impact of Kathryn Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Clarke more than expected).

Fields of papers citing papers by Kathryn Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Clarke. The network helps show where Kathryn Clarke may publish in the future.

Co-authorship network of co-authors of Kathryn Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Clarke. A scholar is included among the top collaborators of Kathryn Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Clarke. Kathryn Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 17
2 2
3 290
4 218
5 41

About Kathryn Clarke

Kathryn Clarke is a scholar working on Dermatology, Cancer Research and Oncology, having authored 5 papers that have together received 568 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (2 papers) and Chemotherapy-related skin toxicity (2 papers). The work is most often cited by research in Oncology (488 citations), Cancer Research (147 citations) and Radiology, Nuclear Medicine and Imaging (120 citations). Kathryn Clarke has collaborated with scholars based in United States and Ireland. Frequent co-authors include Harold J. Burstein, Eric P. Winer, Ursula A. Matulonis, Jerry Younger, Leroy M. Parker, Judith Manola, Craig A. Bunnell, Lawrence N. Shulman, Rebecca Gelman and Rochelle Scheib. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Investigational New Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026